glycan G-family glycogene 1 inhibitors (Stelic Institute)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameglycan G-family glycogene 1 inhibitors (Stelic Institute)
Drug Alias Nameglycan G-family glycogene 1 inhibitors (Stelic Institute)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAlzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesStelic Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesStelic Institute
Active IndicationsN/A
Inactive IndicationsAlzheimer DiseaseParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A